Although uncommon, deaths from asthma are always tragic. New 2020 guidelines from GINA no longer recommends SABAs for first-line use in asthma except in children aged under 5 years (where evidence is lacking). For more formation click here.
2020 Global Initiative for Asthma (GINA) no longer recommends salbutamol for first line therapy